INTRODUCTION
Infection of mammalian cells with RNA oncornaviruses results in the non-lytic production of type C particles which mature on the host cell membrane and are eventually released into the culture medium. As a consequence of virus infection, host cells begin to express a variety of complex cell surface antigens including the major virus structural protein p27 (Kurth & Bauer, ~973; Nowinski & Peters, I973; Old & Boyse, 1973; Lilly & Steeves, 1974; ~ Yoshiki et al. I974) . Considerable attention has been directed toward the detection and characterization of these antigens (Kahan, I973; Old & Boyse, I973; Lilly & Steeves, I974) and toward the kinetics of virion infection and production (Bader, I97O; Dales & Hanafusa, I97a; Levine et aI. I974; Paskind, Weinberg & Baltimore, I975; Levine & Rosenak, 1976) . Relatively little information however has appeared dealing with the kinetics of synthesis of the virion associated cell surface antigens.
The experiments reported here examine the kinetics of biosynthesis of feline leukaemia virus associated cell surface antigens (FeLV-CSA) in the presence of three inhibitors of cellular and/or virion gene expression: actinomycin D (transcription), cordycepin (RNA 'processing') and cycloheximide (translation). These results are related to the effects of the same antimetabolites of FeLV production.
Re-growth of FeLV-CSA following tryvtic removal and the time det)endent decay of FeLV-CSA in the presence of antimetabolites were monitored using a radioimmune assay. Approximately 4o % of the FeLV-associated cell surface antigen was identical with the internal FeLV protein, p27. FeLV-p27 turned over every 8 to Io h as did the mixture of FeLV-CSA. The lifetime of all FeLV-CSA associated mRNAs was a minimum of 9 to 1o h. The relationhip between virion and CSA biosynthesis is discussed.
METHODS
Cell cultures. Pseudodiploid feline lymphoid leukaemia cells (FL-74 also called FLA) were established in a static suspension culture from a solid filtrate of a leukaemic cat's kidney (Theilen et al. I969) . These cultures are infected with and continually produce the FL-74 strain of FeLV (Sarma & Log, I973) . Cultures were maintained in exponential growth phase at 37 °C in RPMI-I64o medium supplemented with Io % foetal bovine serum as previously described (Boone, Gordin & Kawakami, 1973) . In the absence of uninfected FL-74 as a control cell, a secondary feline kidney culture prepared by Flow Laboratories was used as a virus negative control.
Antisera. Autologous bovine antiserum was prepared by infecting a portion of thymic tissue from a young steer with I969) in vitro and inoculating these cells back into the donor. The serum was a gift from Dr T. Kawakami. The immune serum would include only those antibodies induced against antigens associated with infection. Monospecific goat antiserum prepared against FeLV-p27, which was purified by gel filtration in 6 u-guanidine hydrochloride by Dr R. Wilsnack, was obtained through the Virus Cancer Program of NCI. FeLV-p27, purified by isoelectric focusing, was kindly provided by Dr S. Oroszlan.
Radio-immunoassay. Immune and normal IgG was prepared by ammonium sulphate precipitation and labelled catalytically with 131I and 12~I, respectively, as previously described (Boone, Irving & Rubinstein, I97I ; O'Brien et al. I976a ). An equimolar mixture of radiolabelled immune and normal IgG, the paired label mixture (PLM), was absorbed twice to BALB/c mouse fibroblasts (virus and CSA negative) at a concentration of IO 7 cells/rag immune IgG for 30 rain at 27 °C to remove non-specific binding protein. To estimate surface antigens, test cells were incubated with the PLM in 1 ml PBS supplemented with Io % foetal bovine serum for 30 rain, washed and counted in a Packard gamma counter. The FeLV-CSA measured in reported experiments is expressed as ng immune serum bound minus ng normal serum bound.
Enzymatic removal and re-expression of CSA. Five million viable FL-74 cells were washed twice with Hanks BSS and resuspended in I ml Hanks BSS containing o.I25 mg trypsin (Sigma) for 3o min at 37 °C. The reaction was terminated by the addition of 2"5 mg ovomucoid trypsin inhibitor. Negative controls for tryptic antigen removal were identical except that ovomucoid and trypsin were added simultaneously at zero time. Re-expression of CSA following trypsin treatment was observed by resuspension of the cells in 4 ml complete medium at 37 °C.
Inhibitors. Three metabolic inhibitors, all purchased from Sigma Chemical Co., were * Concentration of antimetabolite in #g/ml which inhibited ~< 5 % to >i 95 % of the measured activity respectively.
t Protein synthesis was estimated by the amount of 6H-leucine incorporated by 5 x lO 6 FL-74 cells in 3 ml of culture medium at 37 °C for 1 h. ~: RNA synthesis was estimated by incubating 5 x io 6 FL-74 ceils at 37 °C in increasing concentrations of the indicated inhibitor plus 5 #Ci 3H-uridine (Schwarz-Mann). Labelled RNA was precipitated with lO% TCA and washed on Millipore filters. § mRNA synthesis: cells were pulsed with o'o5/xg actinomycin D/ml for 3o rain to terminate ribosomal RNA synthesis (Mendecki et al. 1972) and then assayed as above for mRNA synthesis.
[I Virion production: FL-74 cells were incubated with increasing concentrations of antibiotics over an 8-h period, and virion production was measured. Conditions are as in Fig. 8 . (Table x) . The cells were then tested for relative viability over a 2o-h period of growth in the presence of each of the antimetabolites at concentrations which were 95 % inhibitory to RNA or protein biosynthesis (Fig. I) . The relative viability of cells incubated in medium supplemented with actinomycin D, cordycepin (3'-deoxyadenosine), and cycloheximide did not differ significantly from control cultures in the initial 8 h of any experiment. production was detected by the recovery of particles containing reverse transcriptase from high speed pellets of tissue culture fluid. Reverse transcriptase was assayed using templates from Collaborative Research (Waltham, Mass.) and 3H-labelled substrates from Schwarz/ Mann as described previously (Wu et al. I972) . FL-74 cells were also positive for type C particles as seen in the electron microscope (Fig. 2) .
RESULTS

Estimation of the number of p27 and F e L V antigenic determinants on FL-74 cell surface
The surface antigens which can be produced by infection with FeLV include virion structural proteins as well as host coded surface determinants (Yoshiki et al. 1974; Essex, 1975; W. Jarrett, personal communication) . In order to measure the number of FeLVassociated cell surface antigens, immune serum titrations of a constant FL-74 cell concen- (Boone et al. I97I) . By extrapolation to the region of low cell concentration, it is possible to estimate the maximum amount of IgG which can bind to the cell surface from the results of an immune serum titration (Fig. 3) . For bovine anti-FeSV the extrapolated value is 8oo ng IgG bound per I x ~o 6 cells or 4oo ng/Io G cells. This value represents (400 x lo -6 x 6-o13 x Io23)[(I.5 x Io ~ x Io 9) = :t-6 x ~o 6 bound antibody molecules• cell. For goat anti-FeLV-pz7, the two experiments of Fig. 3 (b) indicate an average binding of I4o ng IgG/zo 6 cells representing 5-6x Io 5 antibody molecules/cell. The number of antigenic sites/cell is therefore the same as or twice these numbers depending upon whether the IgG binds mono-or bivalently to the cell surface.
Specificity of FeLV and FeLV-p27 antisera
The specificity of the goat anti-FeLV p17 serum was shown by the reduction of binding to FL-74 cells following absorption with increasing quantities of purified FeLV and pz7 (Fig. 4) . The absorbing FeLV-pz7 was purified by a different procedure and in a different laboratory from the p17 immunogen (see Methods). Furthermore, SDS-PAGE gels gave a single zone of radioactivity when overloaded with 125I-labelled pz 7 used in the absorptions. The bovine anti-FeLV was completely absorbed with sonicated FeLV (data not shown) o/ and was partially absorbed by purified FeLV-p27 (4o/o, Fig. 41 ) indicating the presence of one or more virus associated antigenic specificities in this serum in addition to p17.
The goat anti-FeLV-p27 was also capable of blocking the binding of bovine anti-FeLV to FL-74 cells (Fig. 4b) . When 3 x io 6 cells were incubated with increasing quantities of anti-p27 IgG for 3o min and subsequently tested for binding of a paired label mixture of 
Enzymic removal of FeL V-CSA
To determine the extent of p27 and total CSA removed by trypsin, FL-74 cells were incubated with trypsin and tested for CSA with anti-p27 and anti-FeLV sera (Fig. 5) . Approximately 7o % of the p27 and 6o to 7o % of the total CSA determinants were removed in the first 2o min of incubation. The residual p27 determinants were resistant to either higher trypsin concentrations or longer exposure periods. Similarly, 3o % of the total FeLVassociated CSA is also refractory to tryptic removal. cells treated for 30 min with trypsin at 37 °C were washed and resuspended in nutrient medium at a concentration of I-2 x io 6 cells/ml for up to I2 h. At various times following trypsin treatment, cells were removed and quantitatively tested for FeLV-p27 (Fig. 6a) . FeLV-p27 re-expression was complete in 6 to 8 h. Trypsin-treated cells were also incubated in the same medium with the addition of one of the following antimetabolites: actinomycin D, cordycepin, or cycloheximide (Fig. 6a) . Cycloheximide, an inhibitor of ribosomal translation, completely inhibited antigen re-synthesis indicating that cellular protein synthesis was necessary for re-expression of CSA. Antigen re-expression proceeded to pre-tryptic levels in the presence of actinomycin D, which blocks RNA synthesis, suggesting the presence of a steady state level of mRNA capable of translation despite the termination of cellular transcription (Levine & Rosenak, I976 ) . Cordycepin is an adenosine analogue which blocks the 'processing' of already transcribed HnRNA in eukaryotic cells, presumably by blocking the post transcriptional addition of polyadenylate (poly A) residues (Adesnik et al. I972; Mendecki, Lee & Brawerman, 1972, Mans& Maale, I975) . The results in Fig. 6 (a) demonstrate that the response of CSA to cordycepin was identical to actinomycin D, indicating that the mRNA specifying these surface antigens was beyond the cordycepin-sensitive stage of RNA processing. FL-74 cells were also tested for the kinetics of re-growth of the mixture of cell surface antigens detected by FeLV antiserum (Fig. 6b) . The results were similar to the pattern of p27 synthesis. Re-growth occurred in approx. 6 h and was completely inhibited by cycloheximide. Actinomycin and cordycepin were ineffective in preventing antigen reappearance despite their effect on RNA production (Table I) , although there was a slight decrease in the rate of antigen synthesis. 
Re
Kinetics of FeLV-CSA decay in presence of metabolic inhibition
To obtain an estimation of the average lifetime and turnover rate of FeLV-associated cell surface antigens, the rates of antigen decay were measured in the presence of three drugs using the two antisera (Fig. 7) . Cell surface FeLV-pz7 was not affected by RNA inhibitory concentrations of actinomycin and cordycepin until IO to I2 h of exposure. Since non-specific cytotoxicity occurs after IO h with actinomycin D and cordycepin (Fig. I) , the i o to 12 h measurement is interpreted as a minimum estimate of the mRNA lifetime. Cessation of protein synthesis by cycloheximide causes an immediate reduction in p27 detectable after I h and which continues to decrease for up to 6 h of exposure when 8o % of cell surface pz7 has been removed. This result indicates that cell surface pz 7 has a mean lifetime of approx. 6 h.
The total FeLV-CSA population is likewise insensitive to IO to IZ h of incubation with actinomycin D and cordycepin (Fig. 7 b) . Again these results are consistent with the presence of a virus-associated mRNA which has passed the cordycepin sensitive stage of RNA processing and has a minimum lifetime of Io to 12 h. Cycloheximide-associated decay of FeLV-CSA was also detectable as early as I h after exposure and continued until nearly 5o % was removed in 5 to 6 h. The plateau reached in the decay experiments with the FeSV antiserum suggests an even more stable antigenic component which is insensitive to 16 h of cycloheximide and actinomycin.
FL-74 virus associated reverse transcriptase
FL-74 cells release type C virions into the tissue culture medium. Particulate virus was isolated by high speed uItracentrifugation of filtered (o'45 #m) culture fluid and examined for template and ion requirements as described in Methods (Table 2 ). Both Mg ~+ and Mn 2+ serve to satisfy the enzyme's requirement, but Mn ~+ is clearly more effective. EDTA effectively chelated the ions at low concentration resulting in lowered enzyme activity. The FL-74 enzyme catalysed the polymerization of dGMP, but far less efficiently than dTMP under optimal conditions for either divalent cation. Because of the specificity of the templates (Baltimore & Smoler, 1971 ; Robert et al. I972) , and the absence of RDDP activity in normal feline kidney cell fluid, we conclude that our assay is specific for virion particles and not cellular polymerase. 
Inhibition kinetics of FeLV particles with specific inhibitors
The kinetics of virion production by FL-74 cells over an 8-h period in the presence of the various inhibitors is presented in Fig. 8 . In the initial 2 h, only cycloheximide inhibited virion production. In this period, blocking of mRNA production by either actinomycin or cordycepin had no effect. After 3 to 4 h, however, virion production was terminated completely by actinomycin, and partially by cordycepin, continuing in the latter case for another 3 h. These data indicate that the shortest lived RNA species whose transcription is necessary for virion RDDP production has an average lifetime of between z and 4 h, and that apparently a longer-lived RNA component which is critical for virion assembly is blocked by actinomycin D but not by cordycepin.
Titration curves of the inhibition of virus production with actinomycin and cordycepin were performed. The range of inhibition of each of these curves closely corresponded to the ranges of inhibition of RNA and mRNA production (Table Q. This correspondence supports the conclusion that the inhibition of virion and FeLV-CSA production are related to their known roles as metabolic inhibitors and not to non-specific cytotoxic effects. Additional virus proteins detected on cell surfaces include plo, p3o, and gp7o on mouse cells (Grant et al. 1974; S. J. O'Brien et al. unpublished) , and pI2, pI5, p27 and gp7o on feline infected cells (W. Jarrett, personal communication). The feline oncornavirus cell membrane antigen (FOCMA) has also been detected on cell surfaces of numerous species infected with FeLV (Essex et al. i97i a, b; Essex, I975) . There have been suggestions of host specified but virus induced surface antigens in avian systems (Kurth & Bauer, I973) , and there is indirect evidence that FOCMA is not a virion structural component (Essex, 1975) . Since our broadly reactive anti-FeSV serum detected considerable antigens in addition to p27, we screened a number of feline embryonic tissues with the anti-FeSV serum (S. J. O'Brien, unpublished observations), but failed to detect any cross reacting foetal or tissue antigens (Gold & Freedman, 1965; Ting et al. I972; Kahan, 1973) . We were successful in removing all the reactivities to FL-74 cell surfaces by absorption with filtered, pelleted FL-74 virus. We cannot, however, exclude the co-purification of host coded determinants on cell membrane vesicles with the virus material.
The finding of the virus structural protein p27 on the surface of a cell is somewhat surprising in light of its position within the virus inner core. Grant et al. (1974) have suggested that the protein may be absorbed there as a result of virus disruption in the tissue culture fluid followed by passive absorption. Although a portion of the p27 or p3o may be accounted for by passive absorption, the majority of it cannot since virus negative cells absorb less than 20 % of the total amount of p27 observed on virus-infected cells (O'Brien, Simonson & Boone, I976b). Furthermore, non-virus producing murine and feline cells have been found to express p3o and p27 respectively (Grant et al. 1974) . The experiments presented here and elsewhere (O'Brien et al. I976b ) also indicate that passive absorption plays a small part in p27 and p3o production on the cellular surface membrane because re-growth of p27 and p3o (on feline and murine cells, respectively) is inhibited by cycloheximide even in the presence of medium containing virus.
The loss of FeLV-pz7 in the presence of cycloheximide reaches its limit in approx. 6 h. The re-expression of antigen following enzymic removal occurs in 6 to 8 h. Taken together these data reflect an average turnover rate of 6 h for cell surface p27. Total FeLV-CSA rates of decay, re-growth, and therefore turnover, are nearly identical. This rate is comparable to the synthetic rate of HL-Az surface antigen of 6 h described by Turner et al. (1972) .
Blocking of mRNA production with actinomycin D and cordycepin indicates that the mRNA(s) of the FeLV-p27 have average lifetimes of at least IO h. The time required for the post-tryptic re-expression of antigens in the presence of these drugs supports this conclusion. Ten hours is a minimum lifetime estimate because diminished viability is observed with cells as early as II h after addition of actinomycin D and cordycepin (see Fig. I ). The late decay of antigen observed with these inhibitors may be the result of non-specific cellular pathology. Another reason why the Io-h estimate is minimal stems from the description of Goldstein & Penman (1973) of a ribosomal factor which promotes the association of ribosomes and mRNA, but whose synthesis is inhibited by actinomycin D in HeLa cells. If this factor operatedin the FL-74 cells and had a shorter lifetime than FeLV-CSA mRNA, the observed decay would be earlier than the actual decay. Despite these reservations, our estimate of FeLV-CSA mRNA average lifetime is not at variance with the estimate of a I5-h average lifetime for total L cell mRNA made by Perry & Kelly (1973) .
The response of FeLV production and FeLV-CSA synthesis in the presence of inhibitors of mRNA production were dramatically different. While virion production was affected within 3 h of exposure to actinomycin D or cordycepin (Fig. 8) , FeLV-pz 7 and FeLV-CSA synthesis continues for nearly I o h before actinomycin D or cordycepin effects are observed. These data suggest the existence of two different RNA species which are rate limiting under conditions of inhibition of RNA synthesis: a short-lived virion-limiting RNA, and a more stable mRNA which specified p27 and the additional FeLV-CSA.
Our results are in agreement with the finding of Levine et al. (I974), Levine & Rosenak (i976), and Paskind et al. (I975) , who treated MuLV-producing cells with actinomycin and cycloheximide. Termination of protein synthesis with cycloheximide resulted in a rapid decay in MuLV production as well as virus structural proteins. Actinomycin treated cells continued to produce virion proteins and recognizable C-type particles which were defective in infectivity assays and deficient in genomic 60 to 7oS RNA (Levine et al. I974) . Levine & Rosenak (I976) have postulated the presence of a polyribosomal RNA with a functional half life of 6 to 8 h and a genomic virion RNA with a functional half life of 1.5 to 2 h.
The kinetics of inhibition of FeL¥ production by actinomycin and cordycepin were distinctly different. Virion production is terminated in 2 to 4 h by actinomycin, while it continued at about half speed for up to 6 h in the presence of cordycepin. Although it is possible that the concentration of cordycepin was only partially effective in blocking the cordycepin sensitive steps in virus production, we do not feel this is likely since cordycepin is effective at similar concentrations in blocking RNA synthesis and CSA decay.
Actinomycin blocks transcription while cordycepin inhibits polyadenylation. The difference of the two inhibitors on the kinetics of virus production may also be a reflection of more than one virus RNA species. Gillespie & Gallo (I975) have recently proposed that tumour virus RNA may be 'processed' prior to transcription or 'para-processed' prior to encapsulation into a virus core. Differential sensitivity of actinomycin D and cordycepin might be expected under such a subcellular condition.
